TAILIEUCHUNG - INNOVATIVE RHEUMATOLOGY Edited by Hiroaki Matsuno

First of all, we are delighted to be able to provide the "Innovative Rheumatology" to everyone involved in the treatment and research of rheumatoid arthritis. In recent years, the treatment of Rheumatoid Arthritis has undergone tremendous changes due to methotrexate and biologics in large part. Until a decade ago, avoiding joint destruction in rheumatoid arthritis was not realistic for rheumatologist. However, prevention of joint deterioration is now possible, and the quality of life of patients with rheumatoid arthritis in long-term has been able to improve by advances in treatment. However, there are still many problems to be overcome before achieving the treatment of rheumatoid arthritis. All of. | INNOVATIVE RHEUMATOLOGY Edited by Hiroaki Matsuno Innovative Rheumatology http 55641 Edited by Hiroaki Matsuno Contributors Wahid Ali Khan Mohd. Wajid Ali Khan Mohd Wajid Khan Andrew B Lemmey Stevan Stojanovic Branislav Predrag Belie Rafael Burgos María A. Hidalgo Juan L. Hancke Juan C. Bertoglio Giovanni Ciancio Uta Schurigt Michal Gajewski Przemyslaw Rzodkiewicz Koichiro Komiya Maria Das Gragas Henriques Hiroaki Matsuno Katarzyna Romanowska-Prochnicka Marzena Olesinska Chenqi Zhao Published by InTech Janeza Trdine 9 51000 Rijeka Croatia Copyright 2013 InTech All chapters are Open Access distributed under the Creative Commons Attribution license which allows users to download copy and build upon published articles even for commercial purposes as long as the author and publisher are properly credited which ensures maximum dissemination and a wider impact of our publications. After this work has been published by InTech authors have the right to republish it in whole or part in any publication of which they are the author and to make other personal use of the work. Any republication referencing or personal use of the work must explicitly identify the original source. Notice Statements and opinions expressed in the chapters are these of the individual contributors and not necessarily those of the editors or publisher. No responsibility is accepted for the accuracy of information contained in the published chapters. The publisher assumes no responsibility for any damage or injury to persons or property arising out of the use of any materials instructions methods or ideas contained in the book. Publishing Process Manager Danijela Duric Technical Editor InTech DTP team Cover InTech Design team First published January 2013 Printed in Croatia A free online edition of this book is available at Additional hard copies can be obtained from orders@ Innovative Rheumatology Edited by Hiroaki Matsuno p. cm. ISBN .

• Y học thường thức
• Sphingosine
• Phosphate
• Rheumatoid Arthritis
• Pathological Implications
• Rheumatoid arthritis
• Potential Therapeuti
• BMC Cancer
• Insulin like growth factor receptor
• Breast cancer
• Targeted therapies
• Sphingosine kinase
• Gastroesophageal cancer
• Sphingosine 1 phosphate
• Sphingosine kinase 1
• Sphingosine 1 phopshate lyase
• Phản ứng cô đông L Serin
• Gene mã hóa enzyme Sphingosine 1 phosphate Lyase
• Điều khiển phân bào
• Tế bào miễn dịch
• Điều hòa sinh mạch máu
• Therapeutic Targets
• Biological Agents
• BMC Genomics
• Pseudomonas aeruginosa
• Sphingosine kinase 2
• Bacterial resistance
• Facilitating infection
• Nosocomial infections including pneumonia